期刊文献+

胸腺肽注射液两种工艺的稳定性考察研究

Study on Stability of Two kinds of Technics of Thymosin Injection
下载PDF
导出
摘要 目的:研究胸腺肽注射液的生产工艺,选择出最佳的工艺处方及条件,并考察其质量的稳定性。方法:采用加速稳定性试验考察,时间为6个月,在试验期间的第1个月、2个月、3个月、6个月末各取样一次,按稳定性重点考察项目(外观、pH值、含量%、胸腺肽α1、生物活性)检测。结果:胸腺肽在氯化钠的环境下,含量和活性比较稳定。结论:处方2的工艺条件稳定性好,工艺条件简单,适合大规模生产操作。 Objective:To study the product technic of thymosin injection,To chose the best prescription and condition, and invest,gat the quality stability of thymosin injection.Methods:to investigate the stability of accelerat experiment,The whole period is 6 months,Take a sample at the end of day of the first month、the second month、the third month、and the sixth month.According to the stability investigation item,test its external(appearance、pH、assay、Tal and creature activity) .Results:The assay and activity of thymosin is stabler in the sodium chloride liquid.Conclusion:The second technic prescription and condition is simple and good,and suits to the large -scale production.
作者 吴英 赵亚丽
出处 《黑龙江医药》 CAS 2010年第1期69-71,共3页 Heilongjiang Medicine journal
关键词 胸腺肽注射液 两种工艺 稳定性 thymosin two kinds of technics stability
  • 相关文献

参考文献4

二级参考文献20

  • 1张晓峰,刘红梅.胸腺肽的临床应用概况[J].中国误诊学杂志,2007,7(8):1697-1698. 被引量:6
  • 2张华生.胸腺素制备工艺改进[J].中国药学杂志,1989,24(5):305-305.
  • 3王资君.应用超滤技术对小牛胸腺素组分5的分离[J].解放军医学杂志,1982,7(1):49-49.
  • 4吴捂桐.生物制药工艺[M].北京:中国医药科技出版社,1993.303-305.
  • 5国家药典委员会.中华人民共和国药典[M].北京:化学工业出版社,2005.114.
  • 6CORDERO O J,SARANDESES C S,LOPEZ,et al.Prothymosin alpha receptors on peripheral blood mononuclear cells[J].FEBS Letters,1994,341(1):23.
  • 7BAUMANN C,BADAMXHIAN M,GOLDSTEIN A L,et al.Thymosin α1 antagonism of induced apoptosis of developing thymocytes requires the activation of multiple signal transduction pathways[J].FASEBJ,1996,10(2):A441.
  • 8LAU G K,NANJI A,HOU J,et al.Thymosin alpha1and famcidovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase[J].J Viral Hepat,2002,9(4):280.
  • 9MOSCARELLA S,BUZZELI G,ROMANELLI R G,et al.Interferon and thymosin combination therapy in naive patients with chronic hepatitis C:preliminary results[J].Liver,1998,18(2):366.
  • 10SHERMAN K E,SJOGREN M,CREAGER R L,et al.Combination therapy with thymosin α1 and interferon for the treatment of chronic hepatitis C infection:a randomized,placebo controlled double-blind trial[J].Hepatology,1998,27(5):1128.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部